These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38203661)

  • 1. GLIS1, Correlated with Immune Infiltrates, Is a Potential Prognostic Biomarker in Prostate Cancer.
    Peng Q; Xie T; Wang Y; Ho VW; Teoh JY; Chiu PK; Ng CF
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GLIS1 in Cancer-Associated Fibroblasts Regulates the Migration and Invasion of Ovarian Cancer Cells.
    Kim MJ; Jung D; Park JY; Lee SM; An HJ
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of SEPTIN5 inhibits prostate cancer progression by increasing CD8
    Chang M; He Y; Liu C; Lin R; Huang X; Liang D; Zhang J; Lu Y
    Int J Biol Sci; 2022; 18(16):6035-6051. PubMed ID: 36439885
    [No Abstract]   [Full Text] [Related]  

  • 4. GLIS1, a novel hypoxia-inducible transcription factor, promotes breast cancer cell motility via activation of WNT5A.
    Shimamoto K; Tanimoto K; Fukazawa T; Nakamura H; Kanai A; Bono H; Ono H; Eguchi H; Hirohashi N
    Carcinogenesis; 2020 Sep; 41(9):1184-1194. PubMed ID: 32047936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SNAP25 is a potential prognostic biomarker for prostate cancer.
    Di L; Gu M; Wu Y; Liu G; Zhang L; Li Y; Zhang W
    Cancer Cell Int; 2022 Apr; 22(1):144. PubMed ID: 35392903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solute carrier family 16 member 5 downregulation and its methylation might serve as a prognostic indicator of prostate cancer.
    Meng X; Yuan H; Li W; Xiong Z; Dong W; Xiao W; Zhang X
    IUBMB Life; 2021 Nov; 73(11):1363-1377. PubMed ID: 34549875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MT1G, an emerging ferroptosis-related gene: A novel prognostic biomarker and indicator of immunotherapy sensitivity in prostate cancer.
    Cheng B; Lai Y; Huang H; Peng S; Tang C; Chen J; Luo T; Wu J; He H; Wang Q; Huang H
    Environ Toxicol; 2024 Feb; 39(2):927-941. PubMed ID: 37972062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UBASH3B Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Prostate Cancer.
    Wang Z; Wang Y; Peng M; Yi L
    Front Oncol; 2019; 9():1517. PubMed ID: 32010618
    [No Abstract]   [Full Text] [Related]  

  • 9. Comprehensive analysis the diagnosis, malignant progression and immune infiltrate of ANXA6 in prostate cancer.
    Huang B; Yang K
    Genes Genomics; 2023 Sep; 45(9):1197-1209. PubMed ID: 37311953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prognostic signature consisting of metabolism-related genes and SLC17A4 serves as a potential biomarker of immunotherapeutic prediction in prostate cancer.
    Li H; Gu J; Tian Y; Li S; Zhang H; Dai Z; Wang Z; Zhang N; Peng R
    Front Immunol; 2022; 13():982628. PubMed ID: 36325340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory role for Krüppel-like zinc-finger protein Gli-similar 1 (Glis1) in PMA-treated and psoriatic epidermis.
    Nakanishi G; Kim YS; Nakajima T; Jetten AM
    J Invest Dermatol; 2006 Jan; 126(1):49-60. PubMed ID: 16417217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploration of the Tumor Mutational Burden as a Prognostic Biomarker and Related Hub Gene Identification in Prostate Cancer.
    Wang L; Yao Y; Xu C; Wang X; Wu D; Hong Z
    Technol Cancer Res Treat; 2021; 20():15330338211052154. PubMed ID: 34806485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GLIS1 intervention enhances anti-PD1 therapy for hepatocellular carcinoma by targeting SGK1-STAT3-PD1 pathway.
    Rong D; Wang Y; Liu L; Cao H; Huang T; Liu H; Hao X; Sun G; Sun G; Zheng Z; Kang J; Xia Y; Chen Z; Tang W; Wang X
    J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36787938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAPK8IP2 is a potential prognostic biomarker and promote tumor progression in prostate cancer.
    Zeng Z; He W; Jiang Y; Jiang H; Cheng X; Deng W; Zhou X; Zhang C; Wang G
    BMC Cancer; 2022 Nov; 22(1):1162. PubMed ID: 36357836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of HCG18 and MCM3AP-AS1 That Associate With Bone Metastasis, Poor Prognosis and Increased Abundance of M2 Macrophage Infiltration in Prostate Cancer.
    Chen Y; Chen Z; Mo J; Pang M; Chen Z; Feng F; Xie P; Yang B
    Technol Cancer Res Treat; 2021; 20():1533033821990064. PubMed ID: 33596783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ORC6, a novel prognostic biomarker, correlates with T regulatory cell infiltration in prostate adenocarcinoma: a pan-cancer analysis.
    Lin Y; Zhang Y; Tuo Z; Gao L; Ding D; Bi L; Yu D; Lv Z; Wang J; Chen X
    BMC Cancer; 2023 Mar; 23(1):285. PubMed ID: 36978046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GLIS1-3: Links to Primary Cilium, Reprogramming, Stem Cell Renewal, and Disease.
    Jetten AM; Scoville DW; Kang HS
    Cells; 2022 Jun; 11(11):. PubMed ID: 35681527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EXTL3 could serve as a potential biomarker of prognosis and immunotherapy for prostate cancer and its potential mechanisms.
    Chang P; Chen S; Chang X; Zhu J; Tang Q; Ma L
    Eur J Med Res; 2022 Jul; 27(1):115. PubMed ID: 35818069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large-Scale Transcriptome Data Analysis Identifies KIF2C as a Potential Therapeutic Target Associated With Immune Infiltration in Prostate Cancer.
    Zhang P; Gao H; Ye C; Yan R; Yu L; Xia C; Yang D
    Front Immunol; 2022; 13():905259. PubMed ID: 35720323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma.
    Zhu ZY; Tang N; Wang MF; Zhou JC; Wang JL; Ren HZ; Shi XL
    Front Immunol; 2021; 12():781087. PubMed ID: 35069553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.